Doctor Bruce Wines

Research Officer, Immune Therapies Group


Bruce Wines, (PhD) is a Senior Research Officer of the Burnet Institute and his work is based on the central theme of structural /functional relationships in the immune system focusing on the biology of IgA and IgG receptors and antibodies.

Dr. Wines' PhD work on complement component C1q was at the Biochemistry Department of the University of Sydney with Dr Simon Easterbrook-Smith. In the Biochemical Virology Laboratory at Johns Hopkins with Paula Pitha he studied the dysfunction of the immune system in the retroviral MAIDS disease model. Since then he has worked on Fc receptors focusing on the biology and biochemistry of the main leukocyte IgA receptor, FcalphaRI and the low affinity IgG receptor FcgammaRIIa.

Recently, in collaboration with Prof. John Fraser at the University of Auckland and Dr Paul Ramsland at the Burnet, he has been investigating the staphylococcal superantigen like (SSL) toxins as agents of immune evasion for the major human pathogen Staphylococcus aureus.


  • 2006-present: Senior Research Officer, Burnet Institute, Victoria, Australia
  • 2006-present: Senior Fellow, Department of Immunology, Monash University, Victoria, Australia
  • 2003-present: Senior Fellow, Department of Pathology, University of Melbourne, Victoria, Australia
  • 1994-2006: Senior Research Officer, Austin Research Institute, A&RMC, Victoria, Australia
  • 1992-1994: Senior Associate, Victoria University, Victoria, Australia
  • 1992- Oct 1994: Postdoctoral Fellow, Oncology Center, Johns Hopkins University, Baltimore, Maryland, USA
  • 1990-1992: Research Officer, Centre for Molecular Biology and Medicine, Monash University,Victoria, Australia


  • BSc (Hons), University of Sydney, New South Wales, Australia
  • PhD, University of Sydney, New South Wales, Australia

Projects (4)

Current (4)

  • A unique approach to anti-inflammatory immune therapy

  • Anti-COVID-19 biological drugs for prevention and treatment

  • Antibody mAbs to destroy infection: engineering the next generation treatments

  • Predicting quality and potency of monoclonal and natural antibodies

Publications (56)

2021 (1)

2020 (6)

2019 (5)

2018 (4)

2017 (10)

2016 (3)

2015 (1)

2014 (2)

2012 (1)

2011 (2)

2010 (2)

2009 (1)

2008 (1)

2007 (3)

2006 (5)

2005 (1)

2004 (2)

2003 (1)

2001 (1)

2000 (1)

1999 (2)

1995 (1)

News Articles (4)

2020 (1)

2019 (2)

2018 (1)